Page last updated: 2024-09-03

silicon phthalocyanine pc4 and Benign Neoplasms

silicon phthalocyanine pc4 has been researched along with Benign Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Abrahams, G; Mack, J; Nwahara, N; Nyokong, T; Prinsloo, E1
Li, C; Liu, M1
Gao, Y; Jiao, J; Wang, J; Wong, KL; Zhang, Y; Zou, R1

Reviews

1 review(s) available for silicon phthalocyanine pc4 and Benign Neoplasms

ArticleYear
Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy.
    ChemPlusChem, 2020, Volume: 85, Issue:5

    Topics: Apoptosis; Boron Compounds; Humans; Indoles; Light; Neoplasms; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Rhodamines

2020

Other Studies

2 other study(ies) available for silicon phthalocyanine pc4 and Benign Neoplasms

ArticleYear
A hypoxia responsive silicon phthalocyanine containing naphthquinone axial ligands for photodynamic therapy activity.
    Journal of inorganic biochemistry, 2023, Volume: 239

    Topics: Humans; Hypoxia; Ligands; Liposomes; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prodrugs; Tumor Microenvironment

2023
    ACS applied materials & interfaces, 2021, Mar-03, Volume: 13, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chromium; Doxorubicin; Drug Carriers; Fluorescent Dyes; Gallium; Gallium Radioisotopes; Humans; Indoles; Infrared Rays; Male; Metal Nanoparticles; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Neodymium; Neoplasms; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Porosity; Precision Medicine; Proof of Concept Study

2021